A detailed history of New Age Alpha Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 2,969 shares of HAE stock, worth $149,578. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,969
Holding current value
$149,578
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$56.04 - $74.77 $166,382 - $221,992
2,969 New
2,969 $222 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $2.59B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track New Age Alpha Advisors, LLC Portfolio

Follow New Age Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Age Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Age Alpha Advisors, LLC with notifications on news.